Arecor Therapeutics PLC Cash Flow Quality Index
Arecor Therapeutics PLC cash flow quality index. Arecor Therapeutics PLC (AREC) has a Cash Flow Quality Index of -0.33x as of December 2025. Operating cash flow of GBX-1.15 Million is below net income of GBX3.44 Million, suggesting accrual-heavy earnings not yet converted to cash. See how financially flexible is Arecor Therapeutics PLC to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Arecor Therapeutics PLC (2025–2025)
Cash flow quality index of Arecor Therapeutics PLC from 2025 to 2025. Historical Cash Flow Quality Index for Arecor Therapeutics PLC across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore AREC debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Arecor Therapeutics PLC Cash Flow Quality Index by Year (2025–2025)
Arecor Therapeutics PLC cash flow quality index by year from 2025 to 2025. Year-by-year earnings quality comparison for Arecor Therapeutics PLC. For the full cash flow conversion analysis, see AREC cash flow conversion.
| Year | Quality Index | Operating CF (GBX) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -2.46x | GBX-2.29 Million | GBX932.00K | — |